0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Clinical Issues |

Toxic Shock Syndrome: Management and Long-Term Sequelae

P. JOAN CHESNEY, M.D.; BARBARA A. CRASS, B.Sc.; MARCIA B. POLYAK, M.S.; PHILIP J. WAND, B.Sc.; THOMAS F. WARNER, M.B., B.Ch.; JAMES M. VERGERONT, M.D.; JEFFREY P. DAVIS, M.D.; ROBERT W. TOFTE, M.D.; RUSSELL W. CHESNEY, M.D.; and MERLIN S. BERGDOLL, Ph.D.
[+] Article and Author Information

▸Requests for reprints should be addressed to P. Joan Chesney, M.D.; Department of Pediatrics, H4/447, Clinical Science Center; 600 Highland Ave.; Madison, WI 53792.


© 1982 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1982;96(6_Part_2):847-851. doi:10.7326/0003-4819-96-6-847
Text Size: A A A

Little information is available on the optimal management of toxic shock syndrome and on its sequelae. The most appropriate antibiotic treatment, the efficacy of colloid infusions, and the potential role of gamma globulin preparations have not yet been completely ascertained. Coagulase-positive staphylococci associated with toxic shock syndrome had minimal inhibitory concentrations of 0.06 µg/mL or less to rifampin, 0.25 µg/mL or less to gentamicin, and 0.50 µg/mL or less to both nafcillin and clindamycin. In the 36 patients studied abnormal chest roentgenograms were commoner in those who had received albumin than in those who had not. Radioimmunoassay showed antibody titers to staphylococcal enterotoxin F, a marker protein in toxic shock syndrome, of 1:4000 or more for intravenous gamma globulin (12/15 lots) and 1:40 000 or more for intramuscular gamma globulin. Major sequelae of toxic shock syndrome include late-onset rash, compromised renal function, cyanotic extremities, and prolonged neuromuscular abnormalities.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)